<DOC>
	<DOCNO>NCT00035880</DOCNO>
	<brief_summary>Trial evaluate improvement survival 180 day two therapy ( Atgam versus ABX-CBL , monoclonal antibody ) patient acute graft versus host disease respond steroid therapy .</brief_summary>
	<brief_title>Study Comparing ABX-CBL ( Monoclonal Antibody ) Versus Atgam Patients With Steroid Resistant Acute Graft Versus Host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Recipient single allogeneic stem cell transplant donor type Time post transplant le 100 day Received treatment GVHD steroid Recipient second allogeneic stem cell transplant subsequent lymphocyte product donor post transplant IBMTR index less A Received murine product past Diagnosed chronic GVHD Received Atgam later day 10 post transplant Change prophylactic regimen acute GVHD within 72 hour randomization</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2003</verification_date>
	<keyword>Acute graft versus host disease</keyword>
	<keyword>Stem Cell Transplantation</keyword>
</DOC>